Alzheimer’s Breakthrough: Synthetic THC Pill Proves Effective in Clinical Trial
Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer's ...
Study reveals regional differences in dementia drug use in nursing homes
Variations in the use of antidementia and antipsychotic drugs for nursing home residents with dementia across the United ...
Hosted on MSN5d
The elderly still take too many potentially inappropriate drugs
Moreover, although overall spending on PIMs decreased between 2013 and 2021, seniors' exposure to three categories of PIMs increased during this period: gabapentinoids, proton pump inhibitors (PPIs) ...
verywellhealth5d
Cobenfy: The First New Schizophrenia Drug in Decades
The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...
Medscape6d
Clozapine and Respiratory Infection Risk: What to Know
Recent research is painting a clearer picture of the link between the use of clozapine for schizophrenia and respiratory ...
BioPharma Dive8d
Approval in hand, Bristol Myers sets out to sell first-of-its-kind schizophrenia drug
While momentous, the approval of Cobenfy could also draw attention to an age-old problem in American healthcare: Will insurance barriers keep patients from getting an effective medicine?
FDA Approves Potentially Groundbreaking Schizophrenia Drug
On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel ...
Everyday Health9d
FDA Approves the First New Type of Schizophrenia Drug in Decades
Cobenfy doesn’t have the same severe side effects as older schizophrenia medications — like weight gain, involuntary muscle ...
Medscape9d
FDA OKs First-in-Class Antipsychotic for Schizophrenia
The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.
MedPage Today9d
FDA Approves First Novel Drug for Schizophrenia in Decades
The FDA on Thursday approved xanomeline and trospium chloride (Cobenfy) for schizophrenia in adults, the first new class of ...
IFLScience on MSN9d
First New Schizophrenia Treatment Approach In Decades Gets FDA Approval
The US Food and Drug Administration (FDA) has just approved a new drug for the treatment of schizophrenia. Marketed under the ...
This FDA-approved drug promises a new way to treat schizophrenia
Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than antipsychotic treatments ...